These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10368525)

  • 1. Oral contraceptives and smoking, current considerations: recommendations of a consensus panel.
    Schiff I; Bell WR; Davis V; Kessler CM; Meyers C; Nakajima S; Sexton BJ
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S383-4. PubMed ID: 10368525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits and risks of oral contraceptives.
    Sherif K
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S343-8. PubMed ID: 10368519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease: pathogenesis, epidemiology, and risk among users of oral contraceptives who smoke.
    Castelli WP
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S349-56. PubMed ID: 10368520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States.
    Schwingl PJ; Ory HW; Visness CM
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):241-9. PubMed ID: 9914611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking and use of oral contraceptives: impact on thrombotic diseases.
    Lidegaard O
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S357-63. PubMed ID: 10368521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostatic effects of smoking and oral contraceptive use.
    Fruzzetti F
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S369-74. PubMed ID: 10368523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of smoking on prostacyclin formation and platelet aggregation in users of oral contraceptives.
    Roy S
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S364-8. PubMed ID: 10368522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety implications of transferring the oral contraceptive from prescription-only to over-the-counter status.
    Potts M; Denny C
    Drug Saf; 1995 Dec; 13(6):333-7. PubMed ID: 8652077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contraceptive choices in women with coagulation disorders.
    Comp PC; Zacur HA
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 2):1990-3. PubMed ID: 8512043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated intracranial occlusive disease, oral contraceptives, and cigarette use.
    Levine SR; Fagan SC; Pessin MS; Silbergleit R; Floberg J; Selwa JF; Vogel CM; Welch KM
    Neurology; 1991 Dec; 41(12):1893-901. PubMed ID: 1745344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking and cycle control among oral contraceptive users.
    Rosenberg MJ; Waugh MS; Stevens CM
    Am J Obstet Gynecol; 1996 Feb; 174(2):628-32. PubMed ID: 8623797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
    Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety of oral contraceptives: epidemiologic insights from the first 30 years.
    Grimes DA
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1950-4. PubMed ID: 1605284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptive use and hemodynamic, lipid, and fibrinogen responses to smoking and stress in women.
    Davis MC
    Health Psychol; 1999 Mar; 18(2):122-30. PubMed ID: 10194047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
    Lidegaard O
    BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks of oral contraceptive use in women over 35.
    Stenchever MA
    J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.